Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder

NCT00067912 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00067912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00067912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2003
Completion date
March 31, 2004
Enrollment
480
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression